Glenmark Life Sciences posts Q3 FY24 PAT at Rs. 118.76 Cr

Glenmark Life Sciences posts Q3 FY24 PAT at Rs. 118.76 Cr

By: IPP Bureau

Last updated : January 24, 2024 12:00 am



Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023


Glenmark Life Sciences Ltd has reported Standalone financial results for the period ended December 31, 2023.

Glenmark Life Sciences has posted net profit of Rs. 118.76 crores for the period ended December 31, 2023 as against net profit of Rs. 118.73 crores for the period ended September 30, 2023. The company posted net profit of Rs.104.993 crores for the period ended December 31, 2022.

Glenmark Life Sciences has reported total income of Rs. 574.49 crores during the period ended December 31, 2023 as compared to Rs. 600.73 crores during the period ended September 30, 2023. The company reported total income of Rs.547.339 crores during the period ended December 31, 2022.

For the 9 months period ended December 31, 2023, Glenmark Life Sciences has reported total income of Rs.1755.528 crores as compared to Rs.1566.021 crores during the 9 months period ended December 31, 2022.

The company has posted net profit of Rs.372.952 crores for the 9 months period ended December 31, 2023 as against net profit of Rs.320.604 crores for the 9 months period ended December 31, 2022.

Glenmark Life Sciences

First Published : January 23, 2024 12:00 am